Inclusion Criteria:

- Those who are eligible for this treatment protocol will consist of:

1. Patients with histologically diagnosed lung cancer.

2. Patients receiving therapy should have an ECOG/Zubrod/SWOG performance status of
<3 at the time of the initiation of therapy.

3. All newly diagnosed patients referred to an NMCC Alliance site will be eligible,
as will patients with recurrent disease that are now referred to an NMCCA for
their next therapy (such as those who move from out of state, or are referred
for protocol therapy), though efforts will be made to obtain records of prior
therapy administered elsewhere).

Exclusion Criteria:

- Patients not falling under any of the above criteria are not eligible for the study.

- Withdrawal of the informed consent at any point in the study excludes patient from
the study.